{
  "case_id": "case_0010",
  "provider": "google",
  "status": "processed",
  "patient_demographics": {
    "age": 48.89,
    "sex": "Male",
    "genderIdentity": "Cisgender Male",
    "ancestry": "South Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\n  \nSome more precision is possible than: 'right Optic Nerve'.  \nNamely, in the region of: bilateral optic nerve.\n  \nSome more precision is possible than: 'right Thoracic Spinal Cord'.  \nNamely, in the region of: right T2 spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "right T2 myelopathy",
          "bilateral optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Optic Nerve",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "Thoracic Spinal Cord",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [],
        "imprecise_matches": [
          [
            "right Optic Nerve",
            [
              "bilateral optic nerve (cranial nerve II)"
            ]
          ],
          [
            "right Thoracic Spinal Cord",
            [
              "right T2 myelopathy"
            ]
          ]
        ],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 0,
        "imprecisely_identified_count": 2,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 0.0,
        "proportion_imprecise": 1.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, SLE and ADEM.\n\nOther possible differentials:\n- Neurosyphilis.\n- Also feasible but of low probability: Lyme, Vasculitis and Beh\u00e7et's.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Spinal Cord Neoplasm (plausible for unilateral spinal cord; but atypical for bilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple Sclerosis",
          "Neuromyelitis Optica Spectrum Disorder (NMOSD)",
          "MOG Antibody Disease (MOGAD)",
          "Neurosarcoidosis",
          "Acute Disseminated Encephalomyelitis (ADEM)",
          "Spinal Cord Neoplasm",
          "Systemic Lupus Erythematosus with CNS involvement"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "ADEM",
          "Autoimmune_Myelitis_SLE",
          "MOGAD"
        ],
        "missing_lesion_dx_keys": [
          "Infection_Lyme",
          "Syphilis",
          "CNS_Vasculitis",
          "Behcet_Disease"
        ],
        "missing_common_names": [
          "Neurosyphilis"
        ],
        "missing_low_prob_names": [
          "Lyme",
          "Vasculitis",
          "Beh\u00e7et's"
        ],
        "additional_diagnoses": [
          "Spinal Cord Neoplasm"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 1,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 10,
        "lesion_ddx_matched_count": 6,
        "lesion_ddx_missed_common_count": 1,
        "lesion_ddx_missed_low_prob_count": 3,
        "lesion_ddx_coverage_percentage": 0.6
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain, Cervical Spine and Thoracic Spine and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nBut incomplete, should also consider: MRI Orbits.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, ENA, anti-AQP4, syphilis, ESR, lyme.\n- Could also consider testing: anti-dsDNA, ACE, ANCA.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI Brain with and without gadolinium contrast",
          "MRI Cervical and Thoracic Spine with and without gadolinium contrast",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Serum Glucose",
          "Vitamin B12 and Folate",
          "Thyroid function tests",
          "Aquaporin-4 (AQP4) antibodies",
          "Myelin Oligodendrocyte Glycoprotein (MOG) antibodies",
          "Antinuclear antibodies (ANA)",
          "Extractable nuclear antigen (ENA) panel",
          "HIV serology",
          "Syphilis serology",
          "Lyme disease serology",
          "Lumbar Puncture (for CSF analysis and oligoclonal bands)",
          "Visual Evoked Potentials"
        ],
        "all_identified_ft_keys": [
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "ENA_Panel",
          "LFT",
          "Vitamin_B12",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "Lyme_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Folate",
          "MRI_Thoracic_Spine",
          "HIV_Test",
          "VEP",
          "MRI_Brain",
          "ESR"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "Serum_ACE",
          "ANCA"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 5,
        "primary_tests_found_count": 4,
        "primary_tests_missed_count": 1,
        "primary_tests_coverage_percentage": 0.8,
        "ddx_tests_expected_count": 11,
        "ddx_tests_found_count": 8,
        "ddx_tests_coverage_percentage": 0.7272727272727273
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Steroids would require caution due to comorbidity Type 2 diabetes mellitus.\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous Methylprednisolone",
            "timing": "Start Now",
            "reasons": [
              "To accelerate recovery from acute inflammatory demyelination",
              "Patient exhibits disabling neurological deficits requiring urgent intervention"
            ]
          },
          {
            "treatment": "Proton Pump Inhibitor (e.g., Omeprazole)",
            "timing": "Start Now",
            "reasons": [
              "Gastric protection against high-dose corticosteroids"
            ]
          },
          {
            "treatment": "Physiotherapy and Occupational Therapy",
            "timing": "Start Now",
            "reasons": [
              "To assist with gait rehabilitation and safety due to sensory ataxia and weakness"
            ]
          },
          {
            "treatment": "Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab, Natalizumab)",
            "timing": "Delay",
            "reasons": [
              "Requires definitive diagnosis (MS vs NMOSD vs MOGAD) via antibody status and CSF results",
              "Some MS treatments can exacerbate NMOSD"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous Methylprednisolone",
            "timing": "Start Now",
            "reasons": [
              "To accelerate recovery from acute inflammatory demyelination",
              "Patient exhibits disabling neurological deficits requiring urgent intervention"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse."
              ],
              "contraindications": [
                "Steroids potentially inappropriate due to comorbidity Type 2 diabetes mellitus."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Steroids would require caution due to comorbidity Type 2 diabetes mellitus.\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab, Natalizumab)",
            "timing": "Delay",
            "reasons": [
              "Requires definitive diagnosis (MS vs NMOSD vs MOGAD) via antibody status and CSF results",
              "Some MS treatments can exacerbate NMOSD"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 1,
          "reasons_acknowledged": 1,
          "reasons_missed": 0,
          "reasons_coverage_percentage": 1.0
        }
      }
    }
  }
}